story of the week
Amikacin Liposome Inhalation Suspension for MAC Lung Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of the American Thoracic Society
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Amikacin Liposome Inhalation Suspension for MAC Lung Disease: A 12-Month Open-Label Extension Study
Ann Am Thorac Soc 2020 Dec 16;[EPub Ahead of Print], KL Winthrop, PA Flume, R Thomson, KC Mange, DW Yuen, M Ciesielska, K Morimoto, SJ Ruoss, LR Codecasa, JJ Yim, TK Marras, J van Ingen, RJ Wallace, BA Brown-Elliott, C Coulter, DE GriffithFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.